Literature DB >> 14576832

Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes.

Kathy Boon1, Jennifer B Edwards, I-Mei Siu, Deric Olschner, Charles G Eberhart, Marco A Marra, Robert L Strausberg, Gregory J Riggins.   

Abstract

Over 1.4 million transcript tags expressed in 20 different human medulloblastomas were counted using serial analysis of gene expression. Digital gene expression profiles in the medulloblastoma were compared to multiple regions of the normal human brain, revealing 30 transcripts with high expression in multiple tumors and little or no expression in the normal cerebellum and other adult and pediatric brain regions. Using independent medulloblastoma samples and normal tissue, real-time PCR verified eight of nine selected genes as candidate tumor-associated antigens. Differential protein expression for CD24, prolactin and Topo2A was further confirmed by immunohistochemical analysis using medulloblastoma and normal brain sections and a tissue microarray. The genes highly expressed in the medulloblastoma include PRAME, a cancer-testis antigen and potential targets for immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576832     DOI: 10.1038/sj.onc.1207043

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

Review 1.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

2.  PRAME expression in hairy cell leukemia.

Authors:  Evgeny Arons; Tara Suntum; Inger Margulies; Constance Yuan; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Leuk Res       Date:  2008-03-04       Impact factor: 3.156

3.  Impact of Preferentially Expressed Antigen of Melanoma on the Prognosis of Hepatocellular Carcinoma.

Authors:  Kenji Oyama; Keita Kanki; Hiroki Shimizu; Yohei Kono; Junya Azumi; Kan Toriguchi; Etsuro Hatano; Goshi Shiota
Journal:  Gastrointest Tumors       Date:  2016-08-03

4.  Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.

Authors:  Emma Sandén; Cecilia Dyberg; Cecilia Krona; Edward Visse; Helena Carén; Paul A Northcott; Marcel Kool; Nils Ståhl; Annette Persson; Elisabet Englund; John I Johnsen; Peter Siesjö; Anna Darabi
Journal:  J Neurooncol       Date:  2015-03-29       Impact factor: 4.130

5.  Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells through Specific Regulation of CD24.

Authors:  Vijay Pandey; Yewon Jung; Jian Kang; Michael Steiner; Peng-Xu Qian; Arindam Banerjee; Murray D Mitchell; Zheng-Sheng Wu; Tao Zhu; Dong-Xu Liu; Peter E Lobie
Journal:  Transl Oncol       Date:  2010-08-01       Impact factor: 4.243

6.  CD24 interacts with and promotes the activity of c-src within lipid rafts in breast cancer cells, thereby increasing integrin-dependent adhesion.

Authors:  Petra Baumann; Wilko Thiele; Natascha Cremers; Santoshi Muppala; Justyna Krachulec; Markus Diefenbacher; Olivier Kassel; Giridhar Mudduluru; Heike Allgayer; Margaret Frame; Jonathan P Sleeman
Journal:  Cell Mol Life Sci       Date:  2011-06-28       Impact factor: 9.261

7.  Tumor prognostic factors and the challenge of developing predictive factors.

Authors:  Emma B Holliday; Erik P Sulman
Journal:  Curr Oncol Rep       Date:  2013-02       Impact factor: 5.075

8.  Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.

Authors:  Katayoun Rezvani; Agnes S M Yong; Abdul Tawab; Behnam Jafarpour; Rhoda Eniafe; Stephan Mielke; Bipin N Savani; Keyvan Keyvanfar; Yixin Li; Roger Kurlander; A John Barrett
Journal:  Blood       Date:  2008-11-06       Impact factor: 22.113

Review 9.  Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia.

Authors:  Frances Wadelin; Joel Fulton; Paul A McEwan; Keith A Spriggs; Jonas Emsley; David M Heery
Journal:  Mol Cancer       Date:  2010-08-27       Impact factor: 27.401

10.  Coexpression of neuronatin splice forms promotes medulloblastoma growth.

Authors:  I-Mei Siu; Renyuan Bai; Gary L Gallia; Jennifer B Edwards; Betty M Tyler; Charles G Eberhart; Gregory J Riggins
Journal:  Neuro Oncol       Date:  2008-08-13       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.